Ding Nan

902 total citations · 1 hit paper
22 papers, 688 citations indexed

About

Ding Nan is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Ding Nan has authored 22 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Cancer Research. Recurrent topics in Ding Nan's work include Acute Ischemic Stroke Management (4 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Ding Nan is often cited by papers focused on Acute Ischemic Stroke Management (4 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Ding Nan collaborates with scholars based in China and Australia. Ding Nan's co-authors include Haiqiang Jin, Xiaozhong Qu, Yining Sun, Yining Huang, Weiwei Yu, Haiying Wu, Jingjing Jia, Jianwen Deng, Hong-Jun Hao and Zemou Yu and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Ding Nan

21 papers receiving 676 citations

Hit Papers

Glutamine and cancer: metabolism, immune microenvironment... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ding Nan China 15 240 155 133 126 92 22 688
Junyao Zhu China 15 452 1.9× 116 0.7× 49 0.4× 117 0.9× 40 0.4× 32 883
Elahe Mahdipour Iran 17 431 1.8× 138 0.9× 119 0.9× 52 0.4× 132 1.4× 33 921
Hengjun Zhou China 15 345 1.4× 222 1.4× 110 0.8× 137 1.1× 11 0.1× 54 761
Yaxi Wang China 14 488 2.0× 162 1.0× 125 0.9× 71 0.6× 30 0.3× 58 929
Shihai Xia China 20 385 1.6× 69 0.4× 271 2.0× 165 1.3× 24 0.3× 59 933
Xiangxiang Hu United States 17 337 1.4× 100 0.6× 70 0.5× 172 1.4× 20 0.2× 34 645
Yubin Deng China 14 287 1.2× 85 0.5× 76 0.6× 56 0.4× 15 0.2× 23 812
Huiqin Gao China 13 422 1.8× 189 1.2× 84 0.6× 153 1.2× 26 0.3× 22 837
Guangyu Xu China 16 394 1.6× 138 0.9× 40 0.3× 81 0.6× 18 0.2× 33 873

Countries citing papers authored by Ding Nan

Since Specialization
Citations

This map shows the geographic impact of Ding Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Nan more than expected).

Fields of papers citing papers by Ding Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Nan. The network helps show where Ding Nan may publish in the future.

Co-authorship network of co-authors of Ding Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Ding Nan. A scholar is included among the top collaborators of Ding Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding Nan. Ding Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ju, et al.. (2025). ATAC-Seq Library Preparation of Murine Bone Marrow-Derived Neutrophils. Journal of Visualized Experiments.
2.
Nan, Ding, Weiping Yao, Ruiqi Liu, et al.. (2025). Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Communication and Signaling. 23(1). 45–45. 25 indexed citations breakdown →
3.
Jia, Jingjing, Jianwen Deng, Haiqiang Jin, et al.. (2023). Effect of Dl-3-n-butylphthalide on mitochondrial Cox7c in models of cerebral ischemia/reperfusion injury. Frontiers in Pharmacology. 14. 1084564–1084564. 14 indexed citations
4.
Shen, Zhiyuan, Haiqiang Jin, Qing Peng, et al.. (2021). Co-existence and interrelationship between intracranial artery stenosis and extracranial carotid atherosclerosis in an asymptomatic rural population of 13 villages in northern China. Clinical Neurology and Neurosurgery. 210. 107013–107013. 1 indexed citations
5.
Jia, Jingjing, Haiqiang Jin, Ding Nan, Weiwei Yu, & Yining Huang. (2021). New insights into targeting mitochondria in ischemic injury. APOPTOSIS. 26(3-4). 163–183. 55 indexed citations
6.
Yu, Weiwei, Haiqiang Jin, Jianwen Deng, Ding Nan, & Yining Huang. (2020). A novel SPAST gene mutation identified in a Chinese family with hereditary spastic paraplegia. BMC Medical Genetics. 21(1). 123–123. 2 indexed citations
7.
Wang, Yukai, Ronghua Dou, Xinyi Xie, et al.. (2020). Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease – the SFC BP multicentre study in China. Journal of Hypertension. 38(11). 2270–2278. 14 indexed citations
8.
Nan, Ding, Haiqiang Jin, Di Yang, et al.. (2020). Combination of Polyethylene Glycol-Conjugated Urokinase Nanogels and Urokinase for Acute Ischemic Stroke Therapeutic Implications. Translational Stroke Research. 12(5). 844–857. 21 indexed citations
10.
Nan, Ding, et al.. (2019). MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.. PubMed. 23(14). 6202–6210. 4 indexed citations
11.
Yu, Weiwei, et al.. (2019). <p>A novel PDCD10 gene mutation in cerebral cavernous malformations: a case report and review of the literature</p>. Journal of Pain Research. Volume 12. 1127–1132. 5 indexed citations
12.
Gao, Yuhan, Haiqiang Jin, Ding Nan, et al.. (2019). The Role of T Follicular Helper Cells and T Follicular Regulatory Cells in the Pathogenesis of Autoimmune Hemolytic Anemia. Scientific Reports. 9(1). 19767–19767. 17 indexed citations
13.
Jin, Haiqiang, Hong-Jun Hao, Ding Nan, et al.. (2019). Neuromyelitis optica spectrum disorder coincident with renal clear cell carcinoma. Medicine. 98(6). e14229–e14229. 7 indexed citations
14.
Nan, Ding, Haiqiang Jin, Jianwen Deng, et al.. (2019). Cilostazol ameliorates ischemia/reperfusion‐induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress. The FASEB Journal. 33(9). 10152–10164. 32 indexed citations
15.
Sun, Yining, Ding Nan, Haiqiang Jin, & Xiaozhong Qu. (2019). Recent advances of injectable hydrogels for drug delivery and tissue engineering applications. Polymer Testing. 81. 106283–106283. 184 indexed citations
16.
Nan, Ding, et al.. (2019). KCNQ1OT1 promotes migration and inhibits apoptosis by modulating miR‐185‐5p/Rab14 axis in oral squamous cell carcinoma. Development Growth & Differentiation. 61(9). 466–474. 21 indexed citations
17.
Li, Bowen, Rongrong Chen, Yajuan Zhang, et al.. (2018). RGD Modified Protein–Polymer Conjugates for pH-Triggered Targeted Thrombolysis. ACS Applied Bio Materials. 2(1). 437–446. 29 indexed citations
18.
Jin, Haiqiang, Ding Nan, Mengnan Li, et al.. (2017). In vivo evaluation of urokinase-loaded hollow nanogels for sonothrombolysis on suture embolization-induced acute ischemic stroke rat model. Bioactive Materials. 3(1). 102–109. 43 indexed citations
19.
Jin, Haiqiang, Qing Peng, Ding Nan, et al.. (2017). Prevalence and risk factors of intracranial and extracranial artery stenosis in asymptomatic rural residents of 13 villages in China. BMC Neurology. 17(1). 136–136. 29 indexed citations
20.
Nan, Ding, et al.. (2017). NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2. OncoTargets and Therapy. Volume 10. 4905–4915. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026